Which has stronger valuation & earnings, SLP or DOCS?

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sylvania Platinum £156.52M 1.22 £8.54M £13.93 5.29 Dr. Martens £764.90M 0.97 £68.97M £2.40 32.25

Which has higher earnings and valuation, GEN or SLP?

Genuit Group has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Genuit Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genuit Group £602.10M 1.15 £23.57M £17.80 15.43 Sylvania Platinum £156.52M 1.22 £8.54M £13.93 5.29

Do analysts rate SLP or CNIC?

Sylvania Platinum currently has a consensus target price of GBX 168.50, suggesting a potential upside of 128.63%. Given Sylvania Platinum's stronger consensus rating and higher possible upside, equities analysts plainly believe Sylvania Platinum is more favorable than CentralNic Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sylvania Platinum 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 CentralNic Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable earnings and valuation, SLP or CNIC?

Sylvania Platinum has higher earnings, but lower revenue than CentralNic Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sylvania Platinum £156.52M 1.22 £8.54M £13.93 5.29 CentralNic Group £790.04M 0.00 -£3.18M N/A N/A

Sylvania Platinum (SLP) Competitors

GBX 73.70 -8.30 (-10.12%)

As of 07/31/2026 12:33 PM Eastern

Compare

SLP vs. VTY, DOCS, GEN, WIX, and CNIC

Should you buy Sylvania Platinum stock or one of its competitors? MarketBeat compares Sylvania Platinum with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sylvania Platinum include Vistry Group (VTY), Dr. Martens (DOCS), Genuit Group (GEN), Wickes Group (WIX), and CentralNic Group (CNIC).

How does Sylvania Platinum compare to Vistry Group?

Vistry Group (LON:VTY) and Sylvania Platinum (LON:SLP) are related small-cap companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, media sentiment, profitability, valuation, earnings, risk and institutional ownership.

68.4% of Vistry Group shares are held by institutional investors. Comparatively, 17.0% of Sylvania Platinum shares are held by institutional investors. 1.2% of Vistry Group shares are held by insiders. Comparatively, 4.6% of Sylvania Platinum shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Vistry Group and Vistry Group both had 1 articles in the media. Vistry Group's average media sentiment score of 1.11 beat Sylvania Platinum's score of -1.00 indicating that Vistry Group is being referred to more favorably in the media.

Company	Overall Sentiment
Vistry Group	Positive
Sylvania Platinum	Negative

Vistry Group has a beta of 1.841, meaning that its share price is 84% more volatile than the broader market. Comparatively, Sylvania Platinum has a beta of 1.7602932, meaning that its share price is 76% more volatile than the broader market.

Vistry Group presently has a consensus target price of GBX 463.30, suggesting a potential upside of 58.77%. Sylvania Platinum has a consensus target price of GBX 168.50, suggesting a potential upside of 128.63%. Given Sylvania Platinum's stronger consensus rating and higher probable upside, analysts clearly believe Sylvania Platinum is more favorable than Vistry Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vistry Group	4 Sell rating(s)	4 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.80
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Sylvania Platinum has a net margin of 23.16% compared to Vistry Group's net margin of 3.82%. Sylvania Platinum's return on equity of 14.10% beat Vistry Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vistry Group	3.82%	4.20%	3.43%
Sylvania Platinum	23.16%	14.10%	1.69%

Vistry Group has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Vistry Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vistry Group	£3.61B	0.26	£245.05M	£42.00	6.95
Sylvania Platinum	£156.52M	1.22	£8.54M	£13.93	5.29

Summary

Vistry Group beats Sylvania Platinum on 8 of the 14 factors compared between the two stocks.

How does Sylvania Platinum compare to Dr. Martens?

Sylvania Platinum (LON:SLP) and Dr. Martens (LON:DOCS) are related small-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

In the previous week, Sylvania Platinum and Sylvania Platinum both had 1 articles in the media. Dr. Martens' average media sentiment score of 1.11 beat Sylvania Platinum's score of -1.00 indicating that Dr. Martens is being referred to more favorably in the news media.

Company	Overall Sentiment
Sylvania Platinum	Negative
Dr. Martens	Positive

Sylvania Platinum presently has a consensus target price of GBX 168.50, indicating a potential upside of 128.63%. Dr. Martens has a consensus target price of GBX 105, indicating a potential upside of 35.66%. Given Sylvania Platinum's stronger consensus rating and higher probable upside, research analysts clearly believe Sylvania Platinum is more favorable than Dr. Martens.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Dr. Martens	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Sylvania Platinum has a net margin of 23.16% compared to Dr. Martens' net margin of 3.11%. Sylvania Platinum's return on equity of 14.10% beat Dr. Martens' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sylvania Platinum	23.16%	14.10%	1.69%
Dr. Martens	3.11%	6.89%	8.12%

17.0% of Sylvania Platinum shares are held by institutional investors. Comparatively, 19.1% of Dr. Martens shares are held by institutional investors. 4.6% of Sylvania Platinum shares are held by company insiders. Comparatively, 2.9% of Dr. Martens shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Dr. Martens has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Dr. Martens, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sylvania Platinum	£156.52M	1.22	£8.54M	£13.93	5.29
Dr. Martens	£764.90M	0.97	£68.97M	£2.40	32.25

Sylvania Platinum has a beta of 1.7602932, indicating that its stock price is 76% more volatile than the broader market. Comparatively, Dr. Martens has a beta of 0.245, indicating that its stock price is 76% less volatile than the broader market.

Sylvania Platinum pays an annual dividend of GBX 3.58 per share and has a dividend yield of 4.9%. Dr. Martens pays an annual dividend of GBX 2.55 per share and has a dividend yield of 3.3%. Sylvania Platinum pays out 25.7% of its earnings in the form of a dividend. Dr. Martens pays out 106.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Sylvania Platinum is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Sylvania Platinum beats Dr. Martens on 10 of the 16 factors compared between the two stocks.

How does Sylvania Platinum compare to Genuit Group?

Genuit Group (LON:GEN) and Sylvania Platinum (LON:SLP) are related small-cap companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, profitability, valuation, analyst recommendations, media sentiment, earnings, risk and dividends.

Genuit Group pays an annual dividend of GBX 12.60 per share and has a dividend yield of 4.6%. Sylvania Platinum pays an annual dividend of GBX 3.58 per share and has a dividend yield of 4.9%. Genuit Group pays out 70.8% of its earnings in the form of a dividend. Sylvania Platinum pays out 25.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Sylvania Platinum is clearly the better dividend stock, given its higher yield and lower payout ratio.

In the previous week, Sylvania Platinum had 1 more articles in the media than Genuit Group. MarketBeat recorded 1 mentions for Sylvania Platinum and 0 mentions for Genuit Group. Genuit Group's average media sentiment score of 0.00 beat Sylvania Platinum's score of -1.00 indicating that Genuit Group is being referred to more favorably in the media.

Company	Overall Sentiment
Genuit Group	Neutral
Sylvania Platinum	Negative

Genuit Group has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Genuit Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Genuit Group	£602.10M	1.15	£23.57M	£17.80	15.43
Sylvania Platinum	£156.52M	1.22	£8.54M	£13.93	5.29

Sylvania Platinum has a net margin of 23.16% compared to Genuit Group's net margin of 7.51%. Sylvania Platinum's return on equity of 14.10% beat Genuit Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Genuit Group	7.51%	6.89%	4.59%
Sylvania Platinum	23.16%	14.10%	1.69%

Genuit Group has a beta of 1.463, suggesting that its stock price is 46% more volatile than the broader market. Comparatively, Sylvania Platinum has a beta of 1.7602932, suggesting that its stock price is 76% more volatile than the broader market.

74.4% of Genuit Group shares are held by institutional investors. Comparatively, 17.0% of Sylvania Platinum shares are held by institutional investors. 4.2% of Genuit Group shares are held by company insiders. Comparatively, 4.6% of Sylvania Platinum shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Genuit Group presently has a consensus target price of GBX 430.40, suggesting a potential upside of 56.66%. Sylvania Platinum has a consensus target price of GBX 168.50, suggesting a potential upside of 128.63%. Given Sylvania Platinum's higher possible upside, analysts clearly believe Sylvania Platinum is more favorable than Genuit Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Genuit Group	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Sylvania Platinum beats Genuit Group on 9 of the 17 factors compared between the two stocks.

How does Sylvania Platinum compare to Wickes Group?

Sylvania Platinum (LON:SLP) and Wickes Group (LON:WIX) are related small-cap companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, media sentiment, profitability and earnings.

Sylvania Platinum pays an annual dividend of GBX 3.58 per share and has a dividend yield of 4.9%. Wickes Group pays an annual dividend of GBX 10.90 per share and has a dividend yield of 5.5%. Sylvania Platinum pays out 25.7% of its earnings in the form of a dividend. Wickes Group pays out 66.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, Sylvania Platinum had 1 more articles in the media than Wickes Group. MarketBeat recorded 1 mentions for Sylvania Platinum and 0 mentions for Wickes Group. Wickes Group's average media sentiment score of 0.00 beat Sylvania Platinum's score of -1.00 indicating that Wickes Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Sylvania Platinum	Negative
Wickes Group	Neutral

Wickes Group has higher revenue and earnings than Sylvania Platinum. Sylvania Platinum is trading at a lower price-to-earnings ratio than Wickes Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sylvania Platinum	£156.52M	1.22	£8.54M	£13.93	5.29
Wickes Group	£1.64B	0.26	£29.25M	£16.40	12.01

Sylvania Platinum has a net margin of 23.16% compared to Wickes Group's net margin of 2.35%. Wickes Group's return on equity of 29.52% beat Sylvania Platinum's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sylvania Platinum	23.16%	14.10%	1.69%
Wickes Group	2.35%	29.52%	3.77%

Sylvania Platinum has a beta of 1.7602932, suggesting that its share price is 76% more volatile than the broader market. Comparatively, Wickes Group has a beta of 0.851, suggesting that its share price is 15% less volatile than the broader market.

17.0% of Sylvania Platinum shares are held by institutional investors. Comparatively, 58.6% of Wickes Group shares are held by institutional investors. 4.6% of Sylvania Platinum shares are held by insiders. Comparatively, 0.7% of Wickes Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Sylvania Platinum currently has a consensus price target of GBX 168.50, indicating a potential upside of 128.63%. Wickes Group has a consensus price target of GBX 248, indicating a potential upside of 25.89%. Given Sylvania Platinum's stronger consensus rating and higher probable upside, equities analysts plainly believe Sylvania Platinum is more favorable than Wickes Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Wickes Group	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

Summary

Wickes Group beats Sylvania Platinum on 10 of the 18 factors compared between the two stocks.

How does Sylvania Platinum compare to CentralNic Group?

Sylvania Platinum (LON:SLP) and CentralNic Group (LON:CNIC) are related small-cap companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

Sylvania Platinum has a net margin of 23.16% compared to CentralNic Group's net margin of 0.05%. Sylvania Platinum's return on equity of 14.10% beat CentralNic Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sylvania Platinum	23.16%	14.10%	1.69%
CentralNic Group	0.05%	0.26%	3.89%

Sylvania Platinum has higher earnings, but lower revenue than CentralNic Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sylvania Platinum	£156.52M	1.22	£8.54M	£13.93	5.29
CentralNic Group	£790.04M	0.00	-£3.18M	N/A	N/A

17.0% of Sylvania Platinum shares are held by institutional investors. Comparatively, 50.8% of CentralNic Group shares are held by institutional investors. 4.6% of Sylvania Platinum shares are held by insiders. Comparatively, 23.9% of CentralNic Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sylvania Platinum currently has a consensus target price of GBX 168.50, suggesting a potential upside of 128.63%. Given Sylvania Platinum's stronger consensus rating and higher possible upside, equities analysts plainly believe Sylvania Platinum is more favorable than CentralNic Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sylvania Platinum	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
CentralNic Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Sylvania Platinum pays an annual dividend of GBX 3.58 per share and has a dividend yield of 4.9%. CentralNic Group pays an annual dividend of GBX 1 per share. Sylvania Platinum pays out 25.7% of its earnings in the form of a dividend.

Sylvania Platinum has a beta of 1.7602932, indicating that its share price is 76% more volatile than the broader market. Comparatively, CentralNic Group has a beta of 0.41, indicating that its share price is 59% less volatile than the broader market.

In the previous week, Sylvania Platinum had 1 more articles in the media than CentralNic Group. MarketBeat recorded 1 mentions for Sylvania Platinum and 0 mentions for CentralNic Group. CentralNic Group's average media sentiment score of 0.00 beat Sylvania Platinum's score of -1.00 indicating that CentralNic Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Sylvania Platinum	Negative
CentralNic Group	Neutral

Summary

Sylvania Platinum beats CentralNic Group on 10 of the 16 factors compared between the two stocks.

Get Sylvania Platinum News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SLP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SLP vs. The Competition

Export

Metric	Sylvania Platinum	Metals & Mining Industry	Materials Sector	LON Exchange
Market Cap	£212.24M	£3.53B	£4.64B	£2.78B
Dividend Yield	4.88%	5.28%	4.75%	6.15%
P/E Ratio	5.29	21.28	20.05	368.29
Price / Sales	1.22	7,960.31	4,732.90	83,501.19
Price / Cash	2.19	28.95	26.49	27.89
Price / Book	0.86	9.64	8.15	7.04
Net Income	£8.54M	£122.63M	£155.11M	£5.89B
7 Day Performance	-12.26%	-0.77%	-0.58%	6.44%
1 Month Performance	-11.20%	-3.10%	-2.19%	0.09%
1 Year Performance	8.38%	47.32%	37.96%	63.74%

Sylvania Platinum Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SLP Sylvania Platinum	4.1734 of 5 stars	GBX 73.70 -10.1%	GBX 168.50 +128.6%	+5.0%	£212.24M	£156.52M	5.29	160	Analyst Forecast High Trading Volume
VTY Vistry Group	4.4762 of 5 stars	GBX 279.60 +3.6%	GBX 463.30 +65.7%	-50.0%	£887.98M	£3.61B	6.66	4,400
DOCS Dr. Martens	4.0611 of 5 stars	GBX 75.60 +1.3%	GBX 105 +38.9%	-4.3%	£723.58M	£764.90M	31.50	890	News Coverage
GEN Genuit Group	4.3545 of 5 stars	GBX 275.20 +1.1%	GBX 430.40 +56.4%	-29.6%	£693.72M	£602.10M	15.46	2,700	Gap Down
WIX Wickes Group	4.5194 of 5 stars	GBX 192.20 -0.2%	GBX 250.83 +30.5%	-11.1%	£422.65M	£1.64B	11.72	5,930	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:SLP) was last updated on 8/1/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sylvania Platinum (SLP) Competitors

SLP vs. VTY, DOCS, GEN, WIX, and CNIC

How does Sylvania Platinum compare to Vistry Group?

Summary

How does Sylvania Platinum compare to Dr. Martens?

Summary

How does Sylvania Platinum compare to Genuit Group?

Summary

How does Sylvania Platinum compare to Wickes Group?

Summary

How does Sylvania Platinum compare to CentralNic Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLP vs. The Competition

Sylvania Platinum Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sylvania Platinum (SLP) Competitors

SLP vs. VTY, DOCS, GEN, WIX, and CNIC

How does Sylvania Platinum compare to Vistry Group?

Do institutionals and insiders hold more shares of VTY or SLP?

Does the media refer more to VTY or SLP?

Which has more risk & volatility, VTY or SLP?

Do analysts rate VTY or SLP?

Is VTY or SLP more profitable?

Which has stronger valuation & earnings, VTY or SLP?

Summary

How does Sylvania Platinum compare to Dr. Martens?

Does the media refer more to SLP or DOCS?

Do analysts prefer SLP or DOCS?

Is SLP or DOCS more profitable?

Do insiders & institutionals believe in SLP or DOCS?

Which has stronger valuation & earnings, SLP or DOCS?

Which has more volatility and risk, SLP or DOCS?

Is SLP or DOCS a better dividend stock?

Summary

How does Sylvania Platinum compare to Genuit Group?

Is GEN or SLP a better dividend stock?

Does the media prefer GEN or SLP?

Which has higher earnings and valuation, GEN or SLP?

Is GEN or SLP more profitable?

Which has more risk and volatility, GEN or SLP?

Do institutionals & insiders have more ownership in GEN or SLP?

Do analysts prefer GEN or SLP?

Summary

How does Sylvania Platinum compare to Wickes Group?

Is SLP or WIX a better dividend stock?

Does the media refer more to SLP or WIX?

Which has higher earnings and valuation, SLP or WIX?

Is SLP or WIX more profitable?

Which has more volatility and risk, SLP or WIX?

Do insiders and institutionals have more ownership in SLP or WIX?

Do analysts recommend SLP or WIX?

Summary

How does Sylvania Platinum compare to CentralNic Group?

Is SLP or CNIC more profitable?

Which has preferable earnings and valuation, SLP or CNIC?

Do insiders & institutionals have more ownership in SLP or CNIC?

Do analysts rate SLP or CNIC?

Is SLP or CNIC a better dividend stock?

Which has more risk and volatility, SLP or CNIC?

Does the media favor SLP or CNIC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SLP vs. The Competition

Sylvania Platinum Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools